# Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

> clinical trial · VERIFIED · 2026-07-31

Status: NOT_YET_RECRUITING · Sponsor: Liu Shu · Condition: HER2 + Breast Cancer

- Company: Liu Shu
- Sector: HER2 + Breast Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07739511

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.